UCM710 is an endocannabinoid (eCB) hydrolysis inhibitor that increases the levels of N-arachidonoyl ethanolamine and 2-arachidonoylglycerol in neurons. UCM710 inhibits fatty acid amide hydrolase and alpha/beta-hydrolase domain 6, but not monoacylglycerol lipase[1].
Molecular Weight:
310.47
CAS Number:
[213738-77-3]
Formula:
C19H34O3
Target:
Cannabinoid Receptor
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
